Kalpataru Multiplier Ltd.

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla

BSE1345.35-2.3 (-0.17 %)

PREV CLOSE () 1347.65

OPEN PRICE () 1343.45

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 34538

TODAY'S LOW / HIGH ()1335.35 1357.95

52 WK LOW / HIGH ()891.3 1519

NSE1345.75-1.55 (-0.12 %)

PREV CLOSE() 1347.30

OPEN PRICE () 1347.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1345.75 (822)

VOLUME 1173025

TODAY'S LOW / HIGH() 1335.00 1357.70

52 WK LOW / HIGH ()896.3 1519

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000

Email : contactus@cipla.com

Website : www.cipla.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, Luxembourg, MCX

NEWS

18Apr Announcement under Regulation 30 (LOD
In compliance with the provisions of Regulation 30 (Listing Obligations..

16Apr Cipla, Deep Industries and Bharti Airt
Cipla Health (CHL), the wholly owned subsidiary and consumer healthcare..

16Apr Cipla's arm signs agreement for acquis
Cipla Health (CHL), the wholly owned subsidiary and consumer healthcare..

16Apr Cipla informs about allotment of equit
In compliance with the provisions of Regulation 30 of SEBI (Listing Obli..

08Apr USFDA Inspection At Company'S Manufac
USFDA inspection at Company''s manufacturing facility in Patalganga, Mah..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	11141.4	25134.7
Gross Profit	13807.6	34405.4
Operating Profit	15248.4	42493.7
Net Sales	43813.3	157906

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE) 1455.20 (10.00%)	M.Cap ( in Cr) 846.88
Solara Active Pharma (BSE) 551.45 (16.32%)	M.Cap ( in Cr) 1985.01
Abbott India (BSE) 26131.85 (0.29%)	M.Cap ( in Cr) 55528.36
Windlas Biotech (BSE) 555.05 (6.97%)	M.Cap ( in Cr) 1154.42
Concord Biotech (BSE) 1595.25 (1.05%)	M.Cap ( in Cr) 16688.90

Shareholding Pattern

	PROMOTERS	33.47%
	MUTUAL FUNDS/UTI	16.83%
	NON-INSTITUTION	16.36%
	FI/BANKS/INSURANCE	5.49%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name	Hold(%)
ICICI Pru Nifty Pha...	12.04
Nippon India Nifty ...	12.03
ICICI Pru Nifty Hea...	10.55
Axis NIFTY Healthcare ETF	10.54
Aditya Birla SL Nif...	10.53
Mirae Asset Healthc...	9.62
Aditya Birla SL Pha...	8.31

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App

Mobile Trading IOS App

Call Us 0755-4350141/142/143, 9425008895

Mutual Funds 0755-4276725, 4276726

Email Uskmlho@kalpatarumulti.com